Terms: = Ovarian cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
946 results:
1. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
[TBL] [Abstract] [Full Text] [Related]
2. Intraperitoneal Therapy for ovarian cancer - Some Answers, More Questions, and Missed Opportunities.
Yeku OO
NEJM Evid; 2023 May; 2(5):EVIDe2300048. PubMed ID: 38320025
[TBL] [Abstract] [Full Text] [Related]
3. Reduced healthcare access contributes to delay of care in endometrial cancer.
Fife AJ; Najor AJ; Aspir TB; Haines KE; Vilardo NA; Isani SS; Cowan M; Gressel GM; Ye KQ; Nevadunsky NS; Kuo DY; Lin KY
Gynecol Oncol; 2024 Mar; 182():115-120. PubMed ID: 38262233
[TBL] [Abstract] [Full Text] [Related]
4. Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer.
Chauhan S; Langstraat CL; Fought AJ; McGree ME; Cliby WA; Kumar A
Gynecol Oncol; 2024 Jan; 180():126-131. PubMed ID: 38091771
[TBL] [Abstract] [Full Text] [Related]
5. Hospital Volume and Quality of Care for Emergency Gynecologic Care.
Kalinowska V; Huang Y; Buckley A; St Clair CM; Pua T; Khoury-Collado F; Hou JY; Hershman DL; Wright JD
Obstet Gynecol; 2024 Feb; 143(2):303-311. PubMed ID: 38086058
[TBL] [Abstract] [Full Text] [Related]
6. Multidisciplinary Surgical Approach to Increase Survival for Advanced ovarian cancer in a Tertiary Gynaecological Oncology Centre.
Mulligan K; Corry E; Donohoe F; Glennon K; Vermeulen C; Reid-Schachter G; Thompson C; Walsh T; Shields C; McCormack O; Conneely J; Khan MF; Boyd WD; McVey R; O'Brien D; Treacy A; Mulsow J; Brennan DJ
Ann Surg Oncol; 2024 Jan; 31(1):460-472. PubMed ID: 37875740
[TBL] [Abstract] [Full Text] [Related]
7. Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients.
Barral Y; Borrás A; Carrillo P; Agustí I; Peralta S; Casals G; Fàbregues F; Guimerà M; Corral JM; Calafell JM; Redondo M; Glickman A; Rovira M; Adamo B; Ricart E; Trullàs DM
Clin Transl Oncol; 2024 May; 26(5):1129-1138. PubMed ID: 37872422
[TBL] [Abstract] [Full Text] [Related]
8. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
[TBL] [Abstract] [Full Text] [Related]
9. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract] [Full Text] [Related]
10. Ultra-Processed Food Consumption and Mortality: Three Cohort Studies in the United States and United Kingdom.
Zhao Y; Chen W; Li J; Yi J; Song X; Ni Y; Zhu S; Zhang Z; Xia L; Zhang J; Yang S; Ni J; Lu H; Wang Z; Nie S; Liu L
Am J Prev Med; 2024 Feb; 66(2):315-323. PubMed ID: 37690589
[TBL] [Abstract] [Full Text] [Related]
11. Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer.
Mohrmann S; Kolberg L; Jäger B; Hoffmann J; Nestle-Krämling C; Zwiefel K; Friebe V; Sawicki LM; Bruckmann NM; Jannusch K; Morawitz J; Antoch G; Fehm TN; Kirchner J; Dietzel F
Eur J Surg Oncol; 2023 Nov; 49(11):107031. PubMed ID: 37683424
[TBL] [Abstract] [Full Text] [Related]
12. Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001-2018.
Mazumder H; Husain M; Hossain MF; Mahmud S
PLoS One; 2023; 18(9):e0290994. PubMed ID: 37656713
[TBL] [Abstract] [Full Text] [Related]
13. The Association of Kidney Function and Inflammatory Biomarkers with Epithelial ovarian cancer Risk.
Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
[TBL] [Abstract] [Full Text] [Related]
14. Factors that contribute to the recurrence of mucinous ovarian cancer: Monocenter retrospective evaluation.
Birge O; Bakır MS; Karadag C; Doğan S; Tuncer HA; Simsek T
J Cancer Res Ther; 2023; 19(3):610-616. PubMed ID: 37470583
[TBL] [Abstract] [Full Text] [Related]
15. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.
Newhouse R; Nelissen E; El-Shakankery KH; Rogozińska E; Bain E; Veiga S; Morrison J
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD006910. PubMed ID: 37407274
[TBL] [Abstract] [Full Text] [Related]
16. Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018.
Mah SJ; Carter Ramirez DM; Eiriksson LR; Schnarr K; Gayowsky A; Seow H
Gynecol Oncol; 2023 Aug; 175():169-175. PubMed ID: 37392530
[TBL] [Abstract] [Full Text] [Related]
17. Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial ovarian Carcinomas.
Matsuo K; Matsuzaki S; Maeda M; Rau AR; Yoshihara K; Tamura R; Shimada M; Machida H; Mikami M; Klar M; Roman LD; Wright JD; Sood AK; Gershenson DM
JAMA Netw Open; 2023 Jun; 6(6):e2318602. PubMed ID: 37326992
[TBL] [Abstract] [Full Text] [Related]
18. Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
Su SY
Prev Med; 2023 Jul; 172():107551. PubMed ID: 37211252
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in ovarian cancer, and Mario Negri Gynecologic Oncology Group Groups.
Macchia G; Pezzulla D; Campitelli M; Laliscia C; Fodor A; Bonome P; Draghini L; Ippolito E; De Sanctis V; Ferioli M; Titone F; Balcet V; Di Cataldo V; Russo D; Vicenzi L; Cossa S; Lucci S; Cilla S; Deodato F; Gambacorta MA; Scambia G; Morganti AG; Ferrandina G
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):321-332. PubMed ID: 37150261
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous ovarian cancer Based on Competing Risk Model.
Sun X; Peng Y; Chen J; Lei J; Liu W; Li Z
Am J Clin Oncol; 2023 Aug; 46(8):337-345. PubMed ID: 37146258
[TBL] [Abstract] [Full Text] [Related]
[Next]
